Autosomal Dominant Polycystic Kidney Disease (ADPKD), a common inherited disease leading to progressive renal failure, can be caused by a mutation in either the PKD1 or PKD2 gene. Both genes encode for putative transmembrane proteins, polycystin-1 and polycystin-2, which show significant homology to each other and are believed to interact at their carboxy termini. To identify genes that code for related proteins we searched for homologous sequences in several databases and identified one partial cDNA and two genomic sequences with significant homology to both polycystin-1 and -2. Further analysis revealed one novel gene, PKD2L2, located on chromosome band 5q31, and two recently described genes, PKD2L and PKDREJ, located on chromosome bands 10q31 and 22q13.3, respectively. PKD2L2 and PKD2L, which encode proteins of 613 and 805 amino acids, are approximately 65% similar to polycystin-2. The third gene, PKDREJ, encodes a putative 2253 amino acid protein and shows about 35% similarity to both polycystin-1 and polycystin-2. For all the genes expression was found in testis. Additional expression of PKD2L was observed in retina, brain, liver and spleen by RT-PCR. Analyses of five ADPKD families without clear linkage to either the PKD1 or PKD2 locus showed no linkage to any of the novel loci, excluding these genes as the cause of ADPKD in these families. Although these genes may not be involved in renal cystic diseases, their striking homology to PKD2 and PKD1 implies similar roles and may contribute to elucidating the function of both polycystin-1 and polycystin-2.
Introduction
Polycystin-1 and polycystin-2, proteins encoded by the PKD1 and PKD2 genes, are mutated in the majority of patients with autosomal dominant polycystic kidney disease (ADPKD).
1,2 The function of both proteins is still unclear. The PKD1 gene, located on chromosome band 16p13.3, encodes a putative protein of 4302 amino acids. [3] [4] [5] Most of the gene is reiterated several times more proximal on chromosome 16p. This homologous region encodes three large transcripts, but it is not known whether these transcripts produce functional proteins. 4 Polycystin-1 is predicted to be a transmembrane protein, with a long extracellular tail, 11 transmembrane domains and an intracellular carboxy terminus. 6 The extracellular amino terminal part of polycystin-1 contains several domains, including 16 PKD domains 4, 5, 7 and a REJ domain (receptor for egg jelly), 6, 8 which can be involved in protein-protein or protein-carbohydrate interaction. In vitro studies show that the intracellular carboxy terminal part can trigger a cascade of reactions resulting in the activation of transcription factor AP1. 9 A heterotrimeric G-protein activation sequence in the intracellular carboxy terminal part, which can bind to G o /G i , suggests that polycystin-1 may function as a heterotrimeric G-protein coupled receptor involved in signal transduction. 10 A putative coiled-coil domain at the carboxy terminal part of the polycystin-1 can bind to the carboxy terminus of polycystin-2, a protein encoded by the second ADPKD gene. 11, 12 This gene, PKD2, located on chromosome band 4q22-q23, 13, 14 encodes a putative 968 amino acid protein and is predicted to have an internal amino terminus, six transmembrane domains and an internal carboxy terminus with a calcium binding structure (EF-hand domain). 2 Polycystin-2 shows significant homology to polycystin-1 and to the pore forming units of a number of cation channels. 2, 15 Furthermore, association of polycystin-2 with the transient receptor potential channel 1 (TRPC1) protein has been reported, suggesting a role in ion transport. 15 ADPKD is a commonly inherited renal disease which is characterised by the formation of fluid-filled cysts in the kidneys. 16 About half the ADPKD patients suffer from end-stage renal failure before the age of 60. 17 Cysts can also develop in several other organs, such as the liver, spleen and pancreas. [18] [19] [20] High blood pressure, aneurysms and heart valve abnormalities are additional complications of the disease. 21, 22 In most ADPKD patients a mutation in either the PKD1 or PKD2 gene is responsible for the disease. The majority of identified mutations in both genes leads to a premature translation stop, most likely resulting in truncation of the protein product. [23] [24] [25] [26] Data suggest that ADPKD is a recessive disease at cellular level. In both PKD1 and PKD2 patients, somatic mutations were found in a subset of cysts. [27] [28] [29] Mouse models of both PKD1 and PKD2 support a second hit hypothesis as the cause of cyst formation in the kidneys. [30] [31] [32] In addition to the ADPKD families linked to the PKD1 or PKD2 locus, a few families have been found which are not linked to either locus, suggesting that mutations in at least one additional gene can cause the disease. 33, 34 Because polycystin-1 and polycystin-2 are approximately 25% identical, we searched for possibly related genes by screening several databases for homologous sequences. Consequently, we identified one partial cDNA clone 35 and two genomic sequences with homology on protein level to polycystin-1 and polycystin-2. Here we describe the isolation of one novel gene, PKD2L2, and confirm and extend the findings of two recently published genes, PKD2L 36, 37 and PKDREJ.
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Materials and Methods
Databases
Blast searches of the human database of The Institute for Genomic Research (TIGR; http://www.tigr.org/index.html) and the nr (non-redundant), dbest (expressed sequence tag sites) and htgs (high throughput genomic sequences) databases of the National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov) were performed using the DNA and protein sequences of both the PKD1 gene (GenBank L33243) and the PKD2 gene (GenBank U50928). Sequence data were obtained from the Sanger center (GenBank Z93024, Z79998, AL031034, AL031002 and AC004820), the DOE Joint Genome Institute (GenBank AC006084) and NCBI dbest database (GenBank W27963 and W28231). Alignments of the proteins were performed using clustalW1.7 (http://dot.imgen.bcm.tmc.edu:9331/multi-align/ multi-align.html) and boxshade3.21 (http://www.isrec.isbsib.ch/software/BOX_form.html). The prediction of the transmembrane helices was performed with TMpred (http://www.isrec.isb-sib.ch/software.html), SOSUI (http:/ /www.taut.ac.jp), PSORT program (http://psort.nibb.ac.jp.8800) and predict protein (http://www.embl-heidelberg.de). Coils 2.2 (http://www.isrec.isb-sib.ch/software.html; window 28; MTK matrix) was used for the prediction of coiled-coil structures in the novel gene products. 39, 40 To predict protein domains, the Pfam database (http:/ /www.sanger.ac.uk/pfam), the Prodom database (http://protein.toulouse.inra/fr/prodom.html), the Prints-Prosite scanner (http://www.biochem.ucl.ac.uk/cgi-bin/attwood/SearchPrintsForm2.pl), and a Profile scan (http://www.isrec.isb-sib.ch/ software/PFSCAN_form.html/) were used.
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3' and 5' RACE
A 3' and 5' rapid amplification of cDNA ends (RACE) was performed on approximately 0.05 ng Marathon-ready cDNA (Clontech, Palo Alto, CA, USA) of human foetal brain, human foetal kidney and human testis using 5 pmol genespecific forward or reverse primer and 5 pmol primer AP1. Primers AP1 and AP2 (Clontech, Palo Alto, CA, USA) anneal to marathon adaptor sequences, located on both ends of the Marathon-ready cDNAs. Gene-specific primers were used for the RACE of both PKD2L and PKD2L2 (see Results, Table 3 ). The PCR was performed in long-range pH 8.9 buffer (100 mM Tris-HCl, pH 8.9; 500 mM KCl, 2 mg/ml BSA, 0.1% gelatin and 1.5 mM MgCl 2 ) with 0.2 mM dNTPs. After denaturing the samples for 2 min at 94°C, a mix of 2.4 units amplitaq polymerase and 0.07 units Pfu polymerase was added at 90°C followed by 40 cycles of 10 s at 94°C, 10 s at 65°C and 4 min at 72°C. A booster PCR of 35 cycles was performed on 5 µl of a 1/10 dilution of the PCR products in the same conditions as described above, using a gene-specific forward primer and semi-nested primer AP2.
The RACE products of PKD2L were cloned in the pGEM T-easy vector (Promega, Madison, WI, USA). The cloned fragments and PCR products were sequenced using an ABI 377 (fluorescent) sequencer. We used the Perkin-Elmer Big Dye Terminator Cycle Sequencing Kit in combination with a gene-specific primer, primer AP2, a M13 master primer or a M13 reverse primer for sequencing.
Mapping of PKD2L, PKD2L2 and PKDREJ
The mapping of the PKD2L gene was performed by fluorescence in situ hybridisation (FISH). We used a cloned RACE product of approximately 2 kb of the 3' end of the PKD2L gene (primer F4 to poly A tail) as a probe (Table 3) . A chromosome 10-specific library, pBS10 (kindly provided by Dr JW Gray, UCSF) was used for control staining. 41 The probes were labelled separately by standard nick translation 42 for the PKD2L cDNA in the presence of digoxigenin-11-dUTP (Roche Diagnostics, Almere, The Netherlands) and for the chromosome 10-specific library, in the presence of biotin-14-dATP (Life Technologies, Breda, The Netherlands). Hybridisation, immuno-cytochemical detection and analysis of the slides was performed as described previously. 43 Additionally, a Stanford G3 radiation hybrid panel (Research Genetics, Huntsville, AL, USA) was used for mapping the genes by genomic PCR using primers within the coding sequence of the genes and flanking at least one intron. For the PKD2L gene, primers L1F5 and L1R4 and for the PKD2L2 gene, primers L2F1 and L2R1 were used (Table 3) . Since the PKDREJ gene is intronless, primers could not be chosen to discriminate between genomic and cDNA PCR products. Primers LF1 and LR1 were used for mapping of PKDREJ ( Table 3 ). The PCR was performed as described for the RACE with an annealing temperature of 68°C (PKD2L), 55°C (PKD2L2) and 63°C (PKDREJ). The Stanford website (http://www-shgc.stanford.edu/mapping/rh) was used for analysis of the results. For a precise mapping of PKD2L and PKD2L2, a genomic PCR on several yeast artificial chromosomes (YAC) of the CEPH mega-YAC library 44 was performed. The localisations of the YACs were obtained from the chromosome 10 mapping group (http://www.cric.com/genesequences/index.html) and the Lovett lab homepage (http:/ /www.swmed.edu/home_pages/lovettlab/data.html). Analysis for PKD2L was performed on YACs from contigs 59, 62 and 66 and for PKD2L2 on YACs 773d3, 880g9, 759d5, 737b9, 848d1 and 748b8.
Northern Hybridisation and RT-PCR
Multiple tissue northern blot human II (containing about 2 µg poly A + RNA of spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes), northern blot human foetal II (containing brain, lung, liver and kidney) and multiple tissue northern blot human 12-lane (containing brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung and peripheral blood leukocytes) (Clontech, Palo Alto, CA, USA) were hybridised for 90 min at 68°C in ExpressHyb hybridisation solution (Clontech) with 32 P-α-dCTP labelled cDNA probes. The probes were constructed by PCR on either testis or brain cDNA (Clontech) using PKD2L, PKD2L2 or PKDREJ specific primers (Table 3 ). Northern blot human II and human foetal II were hybridised with three PKD2L probes. The first probe was a testis cDNA 1287 bp PCR fragment (primer L1F4 and L1R4), the second probe was a 671 bp testis cDNA 3' RACE product (primer L1F3 -poly A tail) and the third probe was a brain cDNA 3' RACE product (primer L1F3 -poly A tail), which was 85 bp longer than the testis product due to alternative splicing. The human II, foetal II and human 12-lane northern blot were hybridised with a 1055 bp testis cDNA probe of PKD2L2 (primer L2F3 and L2R1) and a 902 bp testis cDNA probe of PKD1L1 (primer LF1 and LF2), respectively, under the same conditions as described above. As a control both blots were hybridised with a human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe.
Random-primed cDNA of several tissues (brain, spleen, pancreas, testis, thymus, heart, lung, retina, kidney and liver) was used to perform a reverse transcriptase PCR (RT-PCR) using PKD2L-specific primers L1F2 and L1R6 generating a 748 bp (testis, retina and liver) or 833 bp (brain and spleen) product (Table 3) . Control RT-PCRs for PKD1 and PKD2 transcript were performed on the same samples using primers in exons 37 and 44 for PKD1 and primers in exons 1 and 3 for PKD2. PCR conditions as described for RACE with annealing temperatures of 65°C (PKD2L), 60°C (PKD1) and 55°C (PKD2).
Random-primed cDNAs of human skeletal muscle (foetal and adult), placenta, lymphocytes, cortex, testis, foetal kidney, and foetal brain and cDNA of rhesus heart, liver and kidney were used for RT-PCR using PKD2L2 specific primers L2F3 and L2R1 in exon 3 and 8, generating a product of 1055 bp. PCR was performed as described for RACE with an annealing temperature of 52°C.
Results
PKD2L2 Gene
With the aim of identifying sequences related to either the PKD1 or PKD2 gene, we searched in several databases for homologous sequences. Thus we identified the sequence of a genomic clone highly homologous to polycystin-2. This PAC clone DJ0038I10 (GenBank AC004820) on chromosome 5 was partially sequenced by the Sanger center. To obtain the complete cDNA sequence of the gene, specific primers were selected to perform a 3' and 5' RACE. Only the RACE on testis cDNA resulted in specific products. Sequencing of these RACE products yielded a cDNA with a total length of 2205 bp, which contained an open reading frame of 1839 bp, a 3' untranslated region of 323 bp and a poly-A signal. This novel gene, PKD2L2, encodes for a 613 amino acid protein (GenBank accession number AF118125). The gene product is approximately 48% identical and 67% similar to both polycystin-2 and the PKD2L protein ( Figure 1 , Table 1 ). At least two alternatively spliced products were obtained by 5' RACE on testis cDNA, but these fragments reveal additional exons, resulting in short open reading frames (data not shown). The significance of these spliced products is unclear.
During our analyses, the sequence of another PAC clone (9c13, LBNL H127, GenBank AC006084), sequenced by the DOE Joint Genome Institute (Lawrence Berkeley National Laboratory), became available. This clone contains the complete genomic sequence of PKD2L2. The intron-exon structure of the gene was determined and is shown in Table 2 . The gene consists of 14 exons and covers about 51 kb of genomic DNA.
Genomic PCR on a whole genome radiation hybrid panel was performed to confirm the chromosome band 5q31 localisation of PKD2L2. Primers flanking intron 7 of the gene were used. The highest lod score (9.0) was obtained with marker D5S500 (SHGC-11945). A refined localisation of the gene was obtained by PCR on a chromosome 5 YAC-contig around D5S500. Since only the PCR on YAC 848d1 resulted in a product, we could map PKD2L2 between markers D5S479 and D5S414 (Figure 2) .
Expression of the PKD2L2 gene was only observed in testis by both RT-PCR and northern blot analysis. PCR on several cDNAs with a forward primer in exon 3 and a reverse primer in exon 8 resulted in a 1055 bp Figure 1 Comparison between polycystin-2 (PKD2, GenBank U50928), the PKD2-like protein 37 Genes homologous to the PKD1 and PKD2 genes B Veldhuisen et al t fragment in testis cDNA, but no product was seen in the other tissues (data not shown). The 1055 bp PCR product was used as a probe to hybridise adult and foetal northern blots. Four transcripts ranging from 1.2 kb to 2.5 kb were seen in testis, but not in the other tissues tested (Figure 3c ). No expression of PKD2L2 was found on a foetal northern blot (data not shown).
The secondary structure was predicted using several programs. Like PKD2, PKD2L2 is predicted to have 6-8 transmembrane domains. The hydropathy plot of PKD2L2 is shown in Figure 4f . The protein contains a cation channel TRPL motif (amino acids 242-494), a cation channel TM motif (amino acids 291-494) and a channel pore calcium-sodium motif (amino acids 373-494). However, in contrast to PKD2, no putative EF-hand and coiled-coil domain were predicted (Figure 4e ).
PKD2L Gene
Database searches also revealed the sequence of two complementary cDNA clones of 500 bp (GenBank accession numbers W27963 and W28231) from a human retina cDNA sub-library with a remarkably high homology at the protein level to polycystin-2. In order to obtain the rest of the transcript, specific primers were designed (primer L1F2 and L1R3, Table 3 ) to perform a 3' and 5' RACE on testis, foetal brain and foetal kidney Marathon-ready cDNA. A testis cDNA sequence of 2541 bp was obtained which contains a translation stop codon and a poly-A signal but which lacks the 5' end of the transcript. This partial cDNA has an open reading frame of 2290 bp encoding for 763 amino acids with an identity of 53% and a similarity of 67% to polycystin-2 (GenBank accession number AF053316) (Figure 1 ). The highest homology has been found in the region containing transmembrane domains 4, 5 and 6 (73% identity). Recently, a partial cDNA sequence (PKD2L, GenBank AF094827) 36 and a protein sequence (PKDL) 37 of a polycystin-like gene have been reported, which are identical to the sequence we obtained for testis cDNA sequence. Using brain Marathon cDNA for a 3' RACE with primer L1F3 (Table 3) , we obtained an alternatively spliced product with an additional 85 bp compared with the testis cDNA sequence. This product resulted in a different and truncated carboxy terminal end of the protein (Figure 1) . No RACE products were obtained using foetal kidney Marathon cDNA. By FISH and whole genome radiation hybrid mapping, we confirmed the localisation of this gene to chromosome band 10q23-q24 (data not shown). Analysis of the data using the Stanford radiation hybrid mapping website revealed that the gene was linked to marker SHGC-17231 on chromosome 10 with a lod score of 9.5. Marker SHGC-17231 has been mapped between D10S574 and D10S603. A refined localisation of PKD2L was obtained by PCR on a contig consisting of CEPH megaYACs 845h7, 904h9, 846g1, 723a1, 963c11, 912c1 and 751b2, all containing the polymorphic marker D10S603. Further analysis revealed that the CA-repeat of marker D10S603 is actually located within an intron of the gene, and that the reverse primer of this marker is located within the coding sequence of PKD2L (Figure 2) .
To investigate the expression pattern of the gene and the length of its transcript, an adult and foetal northern blot were hybridised with PKD2L specific probes. On the adult northern blot only a small transcript of less than 1.35 kb in thymus was detected (data not shown). No clear signal could be obtained for the other tissues. Hybridisation of a foetal northern blot resulted in a transcript in brain of approximately 6 kb (Figure 3a) . No transcript was observed in foetal lung, liver or kidney. Expression of PKD2L was also detected by means of non-quantitative RT-PCR. A product was found in adult brain, spleen, liver and retina mRNA (data not shown). Both brain and spleen showed the alternatively spliced product as described above. As a control we performed RT-PCR with PKD1 and PKD2-specific primers. A transcript was found in all tissues tested, with the exception of retina mRNA (data not shown).
Several programs were used to predict the secondary structure and domains within the PKD2L protein. Like PKD2, PKD2L is predicted to have 6-8 transmembrane regions with internal amino-and carboxy termini. The hydropathy plot for the PKD2L protein is shown in (Figure 1 ). This helix-loophelix structure can be involved in the binding of calcium and was also predicted to be in polycystin-2. 2 Furthermore, a strong probability for a coiled-coil domain in the carboxy terminus was obtained (Figure 1 , amino acids 652-686) using the Coils 2.2 program (window 28; MTK matrix) (Figure 4c) . A weaker coiled-coil domain was predicted between amino acid positions 714 and 741. In addition to its similarity to polycystin-2, the PKD2L protein also shows homology to the voltage activated calcium channels. Using the profile scan of the Swiss Institute for Experimental Cancer Research (ISREC) and the Sanger database of alignments and HMMs (pfam), three different cation channel motifs were predicted. The transient receptor potential subtype (TRPL) motif (amino acids 312-564, entry PS50272), the six transmembrane (TM) region, non-ligand gated motif (amino acids 361-564, entry PS50266), and a calcium and sodium channel pore region S4-S6 (amino acids 443-564, entry PS 629-657). These motifs are also predicted for polycystin-2.
PKDREJ Gene
Database searches with both polycystin-1 and polycystin-2 also revealed homology with three cosmids on chromosome 22. These cosmids, N5H6 (GenBank Z93024), B5E3 (GenBank Z79998) and N98G1 (GenBank AL031034 and AL031002), sequenced by the Sanger center, contain an open reading frame without introns of 6.7 kb, which encodes for a putative 2253 amino acid protein. This deduced protein not only shows homology to both polycystin-1 and polycystin-2, but also to the sea urchin receptor for egg jelly (SuREJ) 8 protein (Table 1) . Recently, this gene has been described by Hughes et al and designated PKDREJ. 38 Although the homology is not very high, the relationship between this protein and polycystin-1 is
Figure 3 Expression of the PKD2L, PKD2L2 and PKDREJ gene on a foetal northern blot (panel A) and adult northern blot (panels B and C) containing approximately 2 µg poly A + RNA. A PKD2L expression using three probes: a 5' testis cDNA probe (position 225-1512), a 3' testis RACE product (position 1787-poly A tail) and a 3' brain RACE product (position 1787-poly A tail). B PKDREJ expression using a testis cDNA probe (position 1010-1911). C PKD2L2 expression using a testis cDNA probe (position 227-1281). D GAPDH expression used as a control
similar to that between polycystin-1 and polycystin-2 (21%). In addition to the homology with polycystin-1, the amino-terminal half of the PKDREJ protein shows homology to the sea urchin REJ protein, whilst the carboxy terminal part shows homology to polycystin-2, PKD2L, and PKD2L2 ( Figure 5 , Table 1 ). To determine the length and expression pattern of the putative transcript, we hybridised northern blots containing foetal and adult tissues with a 900 bp cDNA probe (primers LF1 and LF2). A transcript of approximately 8 kb was found only in testis, and not in other adult tissues tested (Figure 3b) . No transcript could be
Figure 4 Predictions of the coiled-coil domains (panels A, C and E) using the Coils 2.2 program (window 28; MTK matrix) and the membrane-spanning regions (panel B, D and F) of the PKD2, PKD2L and PKD2L2 proteins. The hydropathy plots were constructed using the TMpredict program of Swiss Institute for Experimental Cancer Research
Genes homologous to the PKD1 and PKD2 genes B Veldhuisen et al t detected on a foetal northern blot (data not shown). These data are in agreement with the expression pattern described by Hughes et al. 38 To confirm the mapping of PKDREJ on chromosome 22 we performed a PCR on a whole genome radiation hybrid panel, generating a 900 bp product. A lod score of 14.7 was obtained with marker SHGC-10573 on chromosome band 22q13.3. The localisation of the gene is shown in Figure 2 . Prediction of the structure of the protein revealed 9-20 transmembrane domains, a lipoxygenase homology 2 region (LH2, amino acid positions 244-1339), a cation channel TRPL motif (transient receptor potential subtype, amino acid positions 1931-2175) and a cation channel TM motif (non-ligand gated, amino acid positions 1933-2175). A lipoxygenase homology 2 region was also predicted for polycystin-1 (amino acid positions 3132-3220).
Homologies of the Paralogues
The homologies of the three new members of the polycystin family were determined using ClustalW7.1 and Boxshade. The result is shown in Table 1 and Figure 5 . The receptor for egg jelly in sea-urchin (SuREJ, GenBank U40832) is included in the table since it shows homology to both polycystin-1 and PKDREJ. No homology was found between SuREJ and polycystin-2 or its paralogues. For polycystin-2, PKD2L, and PKD2L2, the homology stretches over the membrane spanning regions of the proteins and a part Since we lacked the 5′DNA sequence of the PKD2L gene, we designated the first base of the codon encoding a tyrosine at amino acid position 43 ( Figure 1 ) as position 1. This position corresponds to the first position of GenBank accession number AF053316. of the carboxy termini; however, both the aminoterminal and carboxy-terminal ends differ between the three proteins. The putative PKDREJ protein shows the highest score (163) to the SuREJ protein in a BLAST search, but the protein shows homology over its entire length with polycystin-1.
Discussion
The PKD1 and PKD2 gene products show significant homology to each other, and we therefore anticipated that the same would be true for the third PKD gene, which remains to be found. Looking for homology at the protein level, we have identified three genes. Two encode proteins which are highly homologous to polycystin-2 and the third encodes a protein which has significant homology to both polycystin-1 and 2. However, it seems unlikely that one of these genes is the third PKD gene. We have mapped the genes in the genome and checked whether they are linked to the mutation in two Dutch families (PK5360; 8 meioses, 5 affected and PK5082; 22 meioses, 6 affected), one Belgian family (PK5707; 12 meioses, 7 affected), and two Canadian families 45 with ADPKD, which are not linked to either the PKD1 or PKD2 locus. We conclude that, using polymorphic CA-repeat markers (Figure 2 ) none of the three genes is responsible for ADPKD in these families (data not shown). This could mean that either the PKD3 gene product is not homologous to polycystin-1 or -2, or that the gene has not yet been sequenced and submitted to a database. In addition, we were also able to exclude linkage of these genes to polycystic liver disease in one family. 46 Several mouse models with polycystic kidneys do not have defects linked to the syntenic regions of the new loci. [47] [48] [49] [50] [51] [52] [53] Our search leaves us with the interesting result that there are three novel genes, the products of which show significant homology to polycystin-1 and 2. Two of them, the PKD2L and PKD2L2 gene products, have a remarkably high homology to each other and polycystin-2. The high homology suggests that these genes must be functionally related. Therefore it is interesting to determine how the expression patterns of these genes compare with the PKD2 gene.
Recently, two other groups reported the PKD2L gene as a new member of the polycystin family, 36, 37 but no consensus was obtained about the expression pattern. Using probes covering the 5' region (1287 bp) and the 3' end of the gene (671 bp and 756 bp), we observed a transcript on a northern blot of approximately 6 kb in foetal brain. No transcript was detected in adult or other foetal tissues. Additionally, we observed expression in adult brain, spleen, retina, liver, testis and foetal brain by RT-PCR. Using a 1.5 kb cDNA probe covering the 5' end of the coding sequence, largely overlapping with one of the probes described above, Nomura et al showed expression of PKD2L on a northern blot. 37 Transcripts of 1.5 kb and 5.5 kb were seen in both foetal and adult tissues; however, in adult tissue the 1.5 kb transcript was predominant, and only after prolonged autoradiography a 5.5 kb transcript could be observed. In contrast, using a 198 bp cDNA probe from the middle part of the gene, located between the 5' and 3' probes described above, Wu et al showed transcripts of 2.4, 2.7 and 3.0 kb in several adult tissues. 36 No transcripts were detected in foetal tissues. We do not have a satisfactory explanation for these different results generated by the three groups. Alternative splicing and cross-hybridisation with other transcripts are possible explanations.
Interestingly, using RT-PCR, expression of the PKD1 and PKD2 genes was detected in all tissues investigated with the exception of retina, whereas PKD2L is expressed in the retina. On a northern blot Wu et al 36 showed expression of PKD2L in the retina, which is in concordance with our data. It is conceivable that in the retina, PKD2L is a functional homologue of the PKD2 gene. Notably, one mouse mutant with a defect on chromosome 19, the syntenic region of human chromosome bands 10q23-q24, has been reported. 54 This mouse model, Krd, has a 7 cM deletion around the pax2 gene and has kidney and retina defects. Nomura et al 37 showed that PKD2L is deleted in the Krd mouse, but whether deletion of PKD2L contributes to the symptoms remains to be seen. Patients with mutations in only the PAX2 gene show both eye malformations and renal hypoplasia; 55 thus the role of PKD2L in the pathology of Krd mice is uncertain.
For PKD2L2 only a transcript in testis was detected by extensive northern blot analyses as well as by RT-PCR. The size of the largest observed transcript (2.5 kb) is consistent with an open reading frame of 1839 bp and a 3' untranslated region of 323 bp. Several alternatively spliced variants were detected at the 5' end of the gene, which could explain the smaller products. For these alternatively spliced products we did not observe large open reading frames.
There is apparent evidence that polycystin-1 and polycystin-2 interact with each other. It would be most Genes homologous to the PKD1 and PKD2 genes B Veldhuisen et al t interesting to determine the interacting partners of the PKD2L and PKD2L2 gene products. Both PKD2L and PKD2L2 lack the homology to the region of polycystin-2 which is involved in the interaction with polycystin-1. 11, 12 However, using the Lupus algorithm, 39, 40 we found a strong probability for a coiled-coil domain in the C-terminus of the PKD2L protein, suggesting that this protein may interact with other proteins. For PKD2L2 no such region was predicted. A very weak coiled-coil domain was predicted for polycystin-2.
11,12
This region is involved in the formation of homodimers, 12 but has not yet been shown to be involved in binding to other proteins. Possibly the coiled-coil domain of PKD2L is also involved in homodimerisation or heterodimerisation with polycystin-like proteins. The predicted structures of PKD2 and the PKD2-like proteins are similar, with 6-8 transmembrane domains and internal amino and carboxy termini. However, PKD2L2 lacks an EF-hand domain as predicted for PKD2 2 and PKD2L. In addition to the paralogues of polycystin-2, we identified homology of both polycystin-1 and polycystin-2 with sequence of chromosome 22. A putative gene, PKDREJ, encoding for 2253 amino acids was extracted from the genomic sequence. It is striking that PKDREJ is an intronless gene with a large open reading frame of 6759 bp. A transcript of approximately 8 kb, corresponding to the expected size, was detected in testis on a northern blot. Consequently, we were able to exclude PKDREJ as a pseudogene, which is consistent with the data described by Hughes et al. 38 The N-terminal half of the protein shows homology to the SuREJ protein. The SuREJ protein, which is also homologous to a part of polycystin-1, is involved in triggering the acrosome reaction after binding to the egg jelly. 8 In mice, Hughes et al showed expression of PKDREJ in the testis from two weeks after birth to adult life, mirroring the production of mature spermatozoa. 38 These data suggest that PKDREJ is the human homologue of the sea urchin REJ protein, and may be involved in human fertilisation. However, there are several differences. The PKDREJ protein is larger than SuREJ and the structure resembles polycystin-1 as opposed to SuREJ. In addition, several domains of SuREJ, such as the C-type lectin and EGF domain, are not present in PKDREJ. Furthermore the homology of PKDREJ with polycystin-1 extends over almost its entire length (2250 amino acid), whilst the homology with SuREJ extends only over the N-terminal half of PKDREJ. Further investigation of the possible interacting proteins and expression pattern is needed to elucidate the function of this protein.
The identification of a PKD1 paralogue on chromosome 22 seems to be in concordance with the data described by Giles et al. 56 A large number of genes flanking the PKD1 gene on chromosome band 16p13 appear to have paralogues on chromosome bands 22q11-q13. The extent of the homologous area is approximately 12-14 megabases. No PKD1 paralogue has yet been described on chromosome 22, but it is unlikely that PKDREJ is the duplicate of the PKD1 gene. In most cases the identity between the paralogues on chromosomes 16 and 22 exceeds 50%, but this is not the case for PKD1 and PKDREJ. Furthermore, PKDREJ is half the size of PKD1 and does not contain any introns. It seems likely that a retrotransposition event is responsible for the similarity between PKD1 and PKDREJ. In addition to the cosmids containing the PKDREJ open reading frame, we identified a PAC clone on chromosome 22, dJ63G5 (GenBank Z94160), with homology to polycystin-1 (data not shown). Interestingly, this clone not only shows homology to polycystin-1, but also to tuberin-2, the protein encoded by TSC2, a gene which flanks the PKD1 gene on chromosome 16 . Although the homology to both proteins is rather low, this region on chromosome 22 may contain the paralogues of both the PKD1 and TSC2 genes. The identification of polycystin-1 and 2 paralogues is not surprising given the hypothesis that genome duplications have led to the increased number of genes, between invertebrates and vertebrates. 57 During evolution copies of genes diverged, sometimes because of fusion to other genes. An altered regulation of gene expression enabled them to take new functional roles. For example, polycystin-1 and polycystin-2 are widely expressed, 1, 2, 58 whereas the paralogues have a restricted expression pattern. Interestingly, all genes are expressed in the testis, although it is unknown if they are expressed in the same cell types. Immunohistochemical staining should be performed to identify the exact temporal and physical localisation of these proteins. Elucidation of the expression pattern and function in testis may contribute to the understanding of the link between the polycystin family members, which probably have distinct but related functions. Like polycystin-2, PKD2L and PKD2L2 show homology to the voltage gated calcium/sodium channels and to the transient receptor potential (TRP) channels. 2, 15 It is conceivable that PKD2L and PKD2L2 may form (part of) a channel, as has been suggested for polycystin-2.
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The challenge for further research will be investigating what the differences and similarities between the PKD paralogues and PKD1 and PKD2 are as a means to understanding the function of all the members of this family of proteins.
